-
OTA Annual Congress 2024
Part 3 of the PBC Biomed ‘Provisional Fixation’ Education Programme is scheduled to air at the OTA annual conference in Montreal, Canada. Our global panel of surgeon advisors will offer further insight on the future of ‘Provisional Fixation’ and the role of our new #breakthroughdevice OsStic® in changing the outlook on patient treatment. The conference…
-
OMTEC 2024
Join us in Chicago for the 2024 OMTEC event, which will provide an opportunity to connect with some of our key R&D and commercial team members. The theme of this year’s event is ‘Educate. Connect. Empower.’ More information on the event is available here: https://omtecexpo.com/
-
ODT Forum 2024
Our US-based PBC Biomed team members will attend the ODT meeting in Memphis this year, a little over a year on from opening the first US office location. This is the first time PBC Biomed will be exhibiting at the event – we look forward to another opportunity to rub shoulders with the ever-evolving Memphis…
-
PBC Biomed had the pleasure of hosting our Clinical Advisory Board at the Medical Education & Research Institute in Memphis last week, for a development lab focused on OsStic®.
The feedback and insights shared by this group are critical in supporting our development and educational objectives for OsStic®, which was recently awarded #BreakthroughDevice Designation. The group also looked at our other innovation programmes, including a #disruptive technology focused on nerve repair, as well as multiple new hardware concepts. Our R&D team have been working closely with our surgeon…
-
FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler.
Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…
-
ASPN-AAHS-ASRM meetings kick off 2024 Conference Season for PBC Biomed
Brittney Martinez, VP of Business Development and Marketing and Gerard Insley, Chief Science Officer are pictured at the ASPN, AAHS and ASRM joint meeting in Nassau last week. This meeting provided an excellent opportunity for the team to connect with surgeon advisors, industry partners and current clients ahead of an exciting year. Update to follow…
-
2024: A Transformative Year Ahead for PBC Biomed
Driven by our dedicated team as well as our valued industry and academic partners, 2024 is set to become a transformative year for our commercialisation and developmental programmes. We would like to take this opportunity to thank our current partners and friends for your continued support and encouragement – we look forward to sharing further…
-
Canine ex vivo tarsal arthrodesis: Fixation by using a new bone tissue glue.
Researchers from the Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden (SLU) and the Department of Surgery, Blå Stjärnans Djursjukhus, Gothenburg, Sweden; Michael Pujari-Palmer, Odd Viking Höglund, Gustaf Svensson, and Tobias Per Otto Lundin, recently published a paper which examines the fixation capabilities of OsSticTM technology in a canine ex vivo tarsal…
-
Strengthening the Bond Part III at OTA 2023
Thank you to our panel of surgeon experts for another great ‘Strengthening the Bond’ symposium at the Orthopaedic Trauma Association conference last week. They also supported us with product demonstrations at our stand for any attendees interested in learning more about one of most exciting technologies – OsStic. Pictured is Dr Tracey Watson using OsStic with a…
-
Successful OCP Workshop at Bioceramics33
PBC Biomed CSO Gerard Insley is pictured in action during the dedicated #OCP Workshop at the Bioceramics 33 event in Solothurn, Switzerland on October 17th. The purpose of this workshop was to create a forum for the world’s leading experts and industrial representatives to share their latest advances in OCP R&D. Well done to the extended panel of experts who…
Search News Items
Categories
- Awards (5)
- Biomaterials (11)
- Biovet (7)
- Bone Adhesive (11)
- Bone Disease Solution (3)
- Bone Healing (9)
- Certification (1)
- Client (2)
- Collaboration (17)
- Conferences (14)
- Contract Manufacturing (2)
- Day One Trauma Charity (1)
- Development (11)
- Events (47)
- Government Funding (2)
- Lectures (5)
- Medical Devices (8)
- Medical Implants (6)
- Memphis Office (6)
- New Hire (8)
- On TV/Radio (2)
- Press Release (8)
- Publications (7)
- ReFeelNerveRepairSolution (3)
- Regenerative Medicine (9)
- Relationship-building (11)
- Research (11)
- Sports & Social (1)
- Student Placements (2)
- Uncategorized (6)
- Upcoming Events (3)
- US Office (3)